Fertility Services Market Report 2024

The fertility services market size has grown rapidly in recent years. It will grow from $54.12 billion in 2023 to $62.07 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed in the historical period can be ascribed to the elevated prevalence of polycystic ovary syndrome (PCOS), the escalating instances of premature ovarian failure, the upsurge in male infertility, the provision of insurance coverage for in vitro fertilization (IVF) procedures by insurance providers, and the rise in the number of same-sex couples.

The fertility services market size is expected to see rapid growth in the next few years. It will grow to $101.76 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The anticipated growth in the forecast period can be linked to the increasing infertility rate, advancements in fertility treatment technologies, the expanding adoption of fertility services to assist in achieving pregnancy, the growing government initiatives, the rise in disposable income, and the increasing trend of delayed parenthood. Noteworthy trends expected in the forecast period encompass a focus on artificial intelligence in fertility services, technological progress, the implementation of preimplantation genetic testing for aneuploidy screening (PGT-A), the DNA fragmentation index (DFI), blockchain-based fertility service applications, the Internet of Things (IoT) in in-vitro fertilization services, and strategic partnerships and mergers and acquisitions.

The expected rise in infertility rates is set to drive increased demand for fertility services in the forecast period. Various factors related to lifestyle changes, such as obesity, stress or depression, and high alcohol consumption, contribute to the increasing rates of infertility, creating a heightened need for fertility services. As an example, a report from the World Health Organization (WHO) in April 2023 highlighted that millions of individuals worldwide of reproductive age are expected to face challenges with infertility, affecting not only individuals but also families and communities. Globally, an estimated 1 in 6 adults, or approximately 17.5% of the adult population, is projected to grapple with infertility. Thus, the surge in infertility rates is poised to fuel the demand for fertility services in the market.

The anticipated growth of the fertility services market is further driven by the increasing prevalence of Polycystic Ovary Syndrome (PCOS). PCOS, a common hormonal disorder affecting individuals with ovaries during their reproductive years, is on the rise, leading to a higher demand for fertility services such as in-vitro fertilization (IVF) and other assisted reproductive techniques. For example, as of June 2023, the World Health Organization reported that approximately 8-13% of women in their reproductive years are estimated to be affected by PCOS, and a significant portion, as high as 70%, remains undiagnosed globally. Consequently, the growing prevalence of PCOS contributes to the upward trajectory of the fertility services market.

Companies in the fertility services market have observed notable growth in research collaborations and approvals for research funding. Key market players are expected to increase their investment in Research and Development (R&D) to introduce advanced techniques and drugs for fertility treatments. For example, in October 2022, Maven Clinic, a US-based company specializing in telemedicine-based virtual clinics for women's and family health, collaborated with Indira IVF, an India-based infertility specialty clinic chain. The collaboration aimed to provide Maven members in India access to high-quality clinical care, additional benefits, and top-notch virtual family-building care through the Maven platform. Additionally, in February 2021, CooperSurgical, a US-based women's healthcare solutions company, partnered with Virtus Health, an Australia-based fertility services provider. The collaboration focused on digitalization, cryogenics, and reproductive genetics, with initiatives aimed at supporting patients' fertility journeys, including those requiring egg, sperm, or embryo donations.

Major companies in the fertility services market are actively innovating new technologies to optimize In Vitro Fertilization (IVF) procedures and maintain a competitive edge. IVF is a medical procedure that involves combining eggs and sperm outside the body to create embryos, which are then implanted in the uterus to facilitate pregnancy for individuals or couples facing fertility challenges. For example, in October 2022, Alife Health, a US-based medical equipment manufacturing company, launched the Alife Assist platform. This suite of products aims to revolutionize the IVF process by leveraging data-driven insights and artificial intelligence (AI) to support clinical decision-making during crucial IVF stages and streamline fertility clinic operations. The platform includes Stim Assist, Embryo Assist, and Insights, offering comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators, thereby enhancing medication dosing, embryo grading, and real-time performance monitoring to improve the overall patient experience and success rates in IVF procedures.

In December 2021, CooperCompanies, a US-based women's healthcare solutions company, acquired Generate Life Sciences for $1.6 billion. Through this acquisition, CooperSurgical strengthens its selection of fertility centers and Obstetrics/Gynecology (OB/GYNs). Generate Life Sciences is a US-based provider of donor eggs and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage.

Major companies operating in the fertility services market report are Vitrolife, Merck KGaA, Progyny Inc., Monash IVF Group, Virtus Health, Medicover Group, Apollo Hospitals Enterprise Ltd., Integramed America, Inc., The Johns Hopkins Health System Corp, Care Fertility, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility Center, Center for Advanced Reproductive Medicine and Infertility, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Flinders Reproductive Medicine Pty Ltd., Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd., KL Fertility & Gynecology Centre, LIFE - Lahore Institute of Fertility & Endocrinology, Maria Fertility Hospital, Morula IVF, Nepal International Fertility Centre, Repromed, SAFE Fertility Center, Southend Fertility and IVF, Thomson Medical Pte Ltd., TMC Fertility Centre, Victory A.R.T. Laboratory Phils. Inc, Virtus Health, CHA Fertility Center, United Family Hospital, The New Hope Fertility Center, NOVA IVF Fertility, Baby Joy Fertility and IVF, Fortis La Femme, ART Fertility Clinics, Ferticity Fertility Clinic, Milann Fertility Centre, Fertility First, City Fertility Sydney, Westmead Fertility Centre, Demeter Fertility, Adora Fertility, Rainbow Fertility, Monash IVF Group Limited, Mitra Keluarga Karyasehat Tbk PT, Laporan Tahunan, Sarang-i IVF Center, Beyond IVF, Bumrungrad International Hospital, Superior A.R.T, King’s Fertility, Manchester Fertility, St Roch IVF Center, Clinique De La Muette, Institut Marques, Hopital Cochin, iTrust Fertility, Apricity, Agora Clinic, TFP Fertility, Apryl, Fresenius, Endo Health, CCRM Fertility Clinic, ORIGIO, Maven Clinic, Bayonne Centre, Biomedival, Grand Paris Fertility Centre, Ava-Peter Clinic, IVF Russia (The International Centre Of The Reproductive Medicines), Next Generation Clinic, Scandinavia AVA-Peter, Nova Vita Clinic, INVICTA Fertility Clinics, Gyncentrum Fertility Clinic, Md Medical Group, Invo Bioscience, New Hope Fertility Center, Carolinas Fertility Institute, Newlife Fertility Centre, Dallas Fort Worth Fertility Associates, Overlake Reproductive Health, Fertility Center Of Las Vegas, Weill Cornell Medicine - Center For Reproductive Medicine, UCSF Center For Reproductive Health, Brigham And Women's Hospital Center For Infertility And Reproductive Surgery, Columbia University Fertility Center, Duke Fertility Center, Advanced Fertility Center Of Texas, Cleveland Clinic Fertility Center, NYU Langone Fertility Center, Mayo Clinic Assisted Reproductive Technologies Rochester, Massachusetts General Hospital Fertility Center, IVF Canada, Bio Fertility Center, The Mexican Institute For Higher Reproductive Technology (Inmater), Select IVF, Fertility Patagonia, In Vitro Buenos Aires, Halitus Instituto Medico, Pregna Medicina Reproductiva, IVF Panama Centro De Reproduccion Punta Pacifica, Colombian Center For Fertility, Sterility, Carrot Fertility, Oya Care, Kitazato, Dubai Fertility Center, Fakih IVF Fertility Center, Orchid Fertility, Bourn Hall Fertility Clinic, Alboshra IVF Center, George’s Memorial Medical Centre, Nordica Fertility Centre, The Olive Branch Clinic, St. Ives Specialist Hospital, Bridge Clinic Fertility Centre, Cairo Fertility Centre, Queens Fertility Centre, BPE Partners, Cleopatra Hospitals Group.

Fertility treatment refers to a medical intervention aimed at enhancing the likelihood of conceiving a child, with the objective of increasing the chances of successful childbirth.

Within fertility services, various types are available, including fresh non-donor services, frozen non-donor services, egg and embryo banking, fresh donor services, and frozen donor services. In the context of fresh donor egg in vitro fertilization (IVF) cycles, donor eggs are promptly fertilized with the sperm from the male partner, and the resulting fresh embryos are transferred to the recipient. Any remaining embryos can be preserved for potential use in subsequent frozen embryo transfers. Assisted reproductive technology (ART), in-vitro fertilization, and artificial insemination are among the diverse procedures employed in fertility services, catering to both male and female individuals.

The fertility services market research report is one of a series of new reports that provides fertility services market statistics, including fertility services industry global market size, regional shares, competitors with a fertility services market share, detailed fertility services market segments, market trends and opportunities, and any further data you may need to thrive in the fertility services industry. This fertility services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Western Europe was the largest region in the fertility services market in 2023. North America was the second largest region in global fertility services market share. The regions covered in the fertility services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fertility services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The fertility services market includes revenues earned by entities by providing artificial insemination, and intrauterine insemination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.